News
-
-
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research initiates coverage on Cantourage Group SE with a Buy rating and €11 target price, citing resilience to regulatory challenges and growth potential in the European medical cannabis market -
-
-
-
-
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE published strong FY25 results, showing 82% yoy growth. Focus on premium strains in Germany, expanding in UK & Poland. FY26e sales to exceed €100m with improved margins. Valuation undemanding. Analyst maintains BUY rating with €10 PT -